Citizens & Northern Corp Has $2.93 Million Position in The Procter & Gamble Company (NYSE:PG)

Citizens & Northern Corp cut its stake in The Procter & Gamble Company (NYSE:PGFree Report) by 1.5% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 17,778 shares of the company’s stock after selling 277 shares during the period. Procter & Gamble makes up about 0.9% of Citizens & Northern Corp’s portfolio, making the stock its 23rd biggest holding. Citizens & Northern Corp’s holdings in Procter & Gamble were worth $2,932,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors have also recently modified their holdings of the company. HighPoint Advisor Group LLC bought a new position in Procter & Gamble in the fourth quarter valued at approximately $17,696,000. Campbell Wealth Management raised its holdings in shares of Procter & Gamble by 13.1% during the 4th quarter. Campbell Wealth Management now owns 1,988 shares of the company’s stock worth $291,000 after buying an additional 231 shares in the last quarter. V Square Quantitative Management LLC lifted its position in shares of Procter & Gamble by 29.0% during the 1st quarter. V Square Quantitative Management LLC now owns 43,202 shares of the company’s stock worth $7,010,000 after buying an additional 9,716 shares during the last quarter. Metis Global Partners LLC boosted its stake in Procter & Gamble by 15.7% in the fourth quarter. Metis Global Partners LLC now owns 115,039 shares of the company’s stock valued at $16,858,000 after buying an additional 15,599 shares in the last quarter. Finally, Bayesian Capital Management LP grew its position in Procter & Gamble by 43.0% in the fourth quarter. Bayesian Capital Management LP now owns 52,840 shares of the company’s stock valued at $7,743,000 after acquiring an additional 15,900 shares during the last quarter. 65.77% of the stock is currently owned by institutional investors.

Procter & Gamble Stock Performance

Shares of Procter & Gamble stock opened at $171.54 on Friday. The company has a market cap of $404.86 billion, a P/E ratio of 28.03, a PEG ratio of 3.72 and a beta of 0.41. The company has a current ratio of 0.73, a quick ratio of 0.53 and a debt-to-equity ratio of 0.51. The business has a 50-day moving average price of $167.48 and a two-hundred day moving average price of $164.08. The Procter & Gamble Company has a 1-year low of $141.45 and a 1-year high of $171.89.

Procter & Gamble (NYSE:PGGet Free Report) last issued its earnings results on Tuesday, July 30th. The company reported $1.40 earnings per share for the quarter, topping analysts’ consensus estimates of $1.37 by $0.03. The business had revenue of $20.53 billion during the quarter, compared to the consensus estimate of $20.69 billion. Procter & Gamble had a return on equity of 33.46% and a net margin of 17.71%. The firm’s revenue for the quarter was down .1% on a year-over-year basis. During the same period in the previous year, the company posted $1.37 earnings per share. As a group, analysts anticipate that The Procter & Gamble Company will post 6.97 EPS for the current year.

Procter & Gamble Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Thursday, August 15th. Investors of record on Friday, July 19th were paid a dividend of $1.0065 per share. This represents a $4.03 annualized dividend and a yield of 2.35%. The ex-dividend date of this dividend was Friday, July 19th. Procter & Gamble’s dividend payout ratio is presently 65.85%.

Insider Buying and Selling at Procter & Gamble

In other news, insider Susan Street Whaley sold 450 shares of the stock in a transaction dated Tuesday, August 20th. The shares were sold at an average price of $169.22, for a total transaction of $76,149.00. Following the transaction, the insider now owns 13,072 shares of the company’s stock, valued at approximately $2,212,043.84. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. In related news, CEO R. Alexandra Keith sold 3,373 shares of Procter & Gamble stock in a transaction on Monday, August 5th. The shares were sold at an average price of $170.00, for a total value of $573,410.00. Following the completion of the sale, the chief executive officer now owns 21,513 shares of the company’s stock, valued at approximately $3,657,210. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, insider Susan Street Whaley sold 450 shares of the company’s stock in a transaction on Tuesday, August 20th. The stock was sold at an average price of $169.22, for a total transaction of $76,149.00. Following the transaction, the insider now owns 13,072 shares in the company, valued at approximately $2,212,043.84. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 375,553 shares of company stock valued at $63,829,141. Corporate insiders own 0.17% of the company’s stock.

Analyst Upgrades and Downgrades

Several brokerages recently commented on PG. Barclays dropped their price objective on shares of Procter & Gamble from $174.00 to $163.00 and set an “overweight” rating for the company in a research note on Thursday, August 1st. Wolfe Research raised Procter & Gamble to a “strong-buy” rating in a report on Friday, August 23rd. JPMorgan Chase & Co. lowered their target price on Procter & Gamble from $181.00 to $179.00 and set an “overweight” rating for the company in a report on Wednesday, July 31st. DZ Bank raised Procter & Gamble from a “hold” rating to a “buy” rating and set a $190.00 price target on the stock in a research note on Thursday. Finally, Stifel Nicolaus upped their price objective on Procter & Gamble from $157.00 to $161.00 and gave the company a “hold” rating in a research note on Monday, July 22nd. Eight research analysts have rated the stock with a hold rating, fourteen have issued a buy rating and one has issued a strong buy rating to the company. According to MarketBeat, Procter & Gamble has an average rating of “Moderate Buy” and an average target price of $175.79.

Read Our Latest Analysis on Procter & Gamble

Procter & Gamble Company Profile

(Free Report)

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.

Featured Articles

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.